Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
43.98 EUR | -0.50% |
|
-.--% | -.--% |
May. 23 | Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... | ![]() |
May. 23 | Swiss Market Index Closes Little Changed; Julius Bär Gains | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 4.09B | - | ||
+27.67% | 76.83B | C+ | ||
-0.38% | 24.51B | C+ | ||
+7.82% | 8.69B | C | ||
+10.46% | 8.33B | B | ||
-25.33% | 7.53B | B- | ||
+15.02% | 5.21B | B- | ||
-8.45% | 3.86B | B- | ||
-3.20% | 3.54B | B+ | ||
+14.22% | 3.37B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GALE Stock
- G70 Stock
- Ratings Galenica AG